DNA Damage and Repair in the Brain After Cerebral Ischemia
Journal:
Current Topics in Medicinal Chemistry
Volume:
1
Page:
483-495
Author(s):
Philip K. Liu
FKBP Ligands as Novel Therapeutics for Neurological Disorders
Journal:
Mini-Reviews in Medicinal Chemistry
Volume:
1
Page:
377-397
Author(s):
C. Christner, T. Herdegen and G. Fischer
Neurotrophic Factors for the Investigation and Treatment of Movement Disorders
Journal:
Current Medicinal Chemistry - Central Nervous System Agents
Volume:
1
Page:
225-238
Author(s):
J. Garcia de Yebenes and M. P. Sanchez
Current Aspects of Pathophysiology and Cell Dysfunction after Severe Head Injury
Journal:
Current Pharmaceutical Design
Volume:
7
Page:
1475-1503
Author(s):
J. Sahuqillo, M. A. Poca and S. Amoros
Pharmacologic Therapy In Traumatic Brain Injury: Update On Experimental Treatment Strategies
Journal:
Current Pharmaceutical Design
Volume:
7
Page:
1505-1516
Author(s):
H. L. Laurer and T. K. McIntosh
Medical Treatment and Neuroprotection in Traumatic Brain Injury
Journal:
Current Pharmaceutical Design
Volume:
7
Page:
1517-1532
Author(s):
T. Clausen and R. Bullock
Therapeutic Moderate Hypothermia and Fever
Journal:
Current Pharmaceutical Design
Volume:
7
Page:
1533-1536
Author(s):
D. W. Marion
Assessing Outcome in Head Injury Trials
Journal:
Current Pharmaceutical Design
Volume:
7
Page:
1537-1552
Author(s):
J. T.Lindsay Wilson
Neuroprotection by NMDA Receptor Antagonists in a Variety of Neuropathologies
Journal:
Current Drug Targets
Volume:
2
Page:
241-271
Author(s):
Gene C. Palmer
Ifenprodil, a Novel NMDA Receptor Antagonist : Site and Mechanism of Action
Journal:
Current Drug Targets
Volume:
2
Page:
285-298
Author(s):
Keith Williams